ClinicalTrials.gov
ClinicalTrials.gov Menu

Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis (PROTECT-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02142725
Recruitment Status : Terminated (IDMC recommendation)
First Posted : May 20, 2014
Last Update Posted : February 9, 2017
Sponsor:
Information provided by (Responsible Party):
Dr. Falk Pharma GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 11, 2016
  Actual Study Completion Date : December 16, 2016